{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:37:25Z","timestamp":1775446645304,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.anai.2012.06.008","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T08:09:30Z","timestamp":1340784570000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis"],"prefix":"10.1016","volume":"109","author":[{"given":"Ina","family":"Callebaut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Vandewalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Hox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Bobic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jorissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg","family":"Stalmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenis","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 Suppl","key":"10.1016\/j.anai.2012.06.008_bib1","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib2","first-page":"139","article-title":"Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management","volume":"128","author":"W\u00fcthrich","year":"1998","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.anai.2012.06.008_bib3","unstructured":"Agency for Healthcare Research and Quality. Management of Allergic Rhinitis in the Working-Age Population. Evidence Report\/Technology Assessment, Number 67, No 03-E013, January 2003."},{"key":"10.1016\/j.anai.2012.06.008_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1398-9995.2010.02360.x","article-title":"Conjunctival effects of a selective nasal pollen provocation","volume":"65","author":"Callebaut","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1081-1206(10)60442-5","article-title":"Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis","volume":"100","author":"Baroody","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1398-9995.2005.00741.x","article-title":"The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen","volume":"60","author":"O'Meara","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2009.03.015","article-title":"Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms","volume":"123","author":"Baroody","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2222.2004.01952.x","article-title":"Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis","volume":"34","author":"Bernstein","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1398-9995.2007.01522.x","article-title":"Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen","volume":"62","author":"Fokkens","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2007.02.022","article-title":"Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis","volume":"119","author":"Kaiser","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.iac.2007.12.001","article-title":"Ocular allergy treatment","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2012.06.008_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/ACI.0b013e32830d8501","article-title":"Intranasal corticosteroids and allergic rhinoconjunctivitis","volume":"8","author":"Origlieri","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60453-X","article-title":"Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate","volume":"100","author":"Bielory","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00405-010-1420-y","article-title":"Laryngeal effects of nasal allergen provocation in singers with allergic rhinitis","volume":"268","author":"Verguts","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anai.2012.06.008_bib15","doi-asserted-by":"crossref","first-page":"13011307","DOI":"10.1111\/j.1398-9995.2005.00911.x","article-title":"Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients","volume":"60","author":"Reinartz","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mai.2001.113046","article-title":"Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways","volume":"107","author":"Braunstahl","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-7022-1-2","article-title":"Diagnostic tools in Rhinology EAACI position paper","volume":"1","author":"Scadding","year":"2001","journal-title":"Clinical and Translational Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib18","first-page":"2161","article-title":"Increased plasma levels of substance P in vernal keratoconjunctivitis","volume":"38","author":"Lambiase","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.anai.2012.06.008_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2222.1997.tb00721.x","article-title":"Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis","volume":"27","author":"Fujishima","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2012.06.008_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","article-title":"The role of substance P in inflammatory disease","volume":"2001","author":"O'Connor","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.anai.2012.06.008_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","article-title":"Neuropeptides activate human mast cell degranulation and chemokine production","volume":"123","author":"Kulka","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.anai.2012.06.008_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/ACI.0b013e32830e6b17","article-title":"The role of neuromediators in ocular allergy","volume":"8","author":"Micera","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib23","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1185\/03007990903094106","article-title":"Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?","volume":"25","author":"Keith","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2012.06.008_bib24","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(11)60130-X","article-title":"Allergic rhinitis","volume":"378","author":"Greiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2012.06.008_bib25","doi-asserted-by":"crossref","first-page":"L544","DOI":"10.1152\/ajplung.00271.2007","article-title":"Sensitization of isolated rat vagal pulmonary sensory neurons by eosinophil-derived cationic proteins","volume":"294","author":"Gu","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.anai.2012.06.008_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0091-6749(88)90177-7","article-title":"Effects of topical nasal treatment on asthma symptoms","volume":"81","author":"Reed","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.06.008_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neubiorev.2006.01.002","article-title":"Olfactory\/trigeminal interactions in nasal chemoreception","volume":"30","author":"Brand","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.anai.2012.06.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0110001","article-title":"Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids","volume":"11","author":"Adcock","year":"1993","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.anai.2012.06.008_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s003950050056","article-title":"Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells","volume":"93","author":"Graf","year":"1998","journal-title":"Basic Res Cardiol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061200436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112061200436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:06:25Z","timestamp":1761051985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112061200436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S108112061200436X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2012.06.008","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2012.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}